CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES

N/A

Manufactured by Jazz Pharmaceuticals, Inc.

22,248 FDA adverse event reports analyzed

Last updated: 2026-04-14

About CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES

CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Jazz Pharmaceuticals, Inc.. The most commonly reported adverse reactions for CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES include PRODUCT ADMINISTRATION INTERRUPTED, SURGERY, NAUSEA, PRODUCT DOSE OMISSION ISSUE, ANXIETY. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES.

Top Adverse Reactions

PRODUCT ADMINISTRATION INTERRUPTED1,480 reports
SURGERY1,054 reports
NAUSEA867 reports
PRODUCT DOSE OMISSION ISSUE805 reports
ANXIETY621 reports
INTENTIONAL DOSE OMISSION544 reports
HEADACHE479 reports
INTENTIONAL PRODUCT USE ISSUE470 reports
DIZZINESS463 reports
SOMNOLENCE436 reports
VOMITING401 reports
FEELING ABNORMAL392 reports
DEPRESSION386 reports
WEIGHT DECREASED375 reports
DRUG INEFFECTIVE363 reports
FALL360 reports
ILLNESS351 reports
HOSPITALISATION350 reports
FATIGUE334 reports
SUICIDAL IDEATION321 reports
COVID 19313 reports
OFF LABEL USE302 reports
INSOMNIA293 reports
DYSPNOEA273 reports
DIARRHOEA242 reports
TREMOR241 reports
HYPERHIDROSIS240 reports
NEPHROLITHIASIS239 reports
CONDITION AGGRAVATED234 reports
MUSCLE SPASMS216 reports
HYPERTENSION210 reports
DRUG HYPERSENSITIVITY208 reports
PAIN208 reports
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS205 reports
NASOPHARYNGITIS197 reports
DECREASED APPETITE193 reports
MIGRAINE193 reports
LOSS OF CONSCIOUSNESS190 reports
PRE EXISTING CONDITION IMPROVED190 reports
ABDOMINAL DISCOMFORT189 reports
MEMORY IMPAIRMENT170 reports
COUGH165 reports
DEPRESSED LEVEL OF CONSCIOUSNESS160 reports
NEUROPATHY PERIPHERAL155 reports
GASTROOESOPHAGEAL REFLUX DISEASE152 reports
SEIZURE152 reports
DRY MOUTH151 reports
BRAIN FOG149 reports
ENURESIS149 reports
PNEUMONIA149 reports
CONFUSIONAL STATE143 reports
SOMNAMBULISM143 reports
TREATMENT NONCOMPLIANCE142 reports
BLOOD PRESSURE INCREASED134 reports
HYPERSENSITIVITY133 reports
HALLUCINATION129 reports
PARAESTHESIA129 reports
HEART RATE INCREASED128 reports
PANIC ATTACK127 reports
CONSTIPATION125 reports
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION125 reports
SLEEP APNOEA SYNDROME124 reports
ARTHRALGIA121 reports
BACK PAIN120 reports
DRUG EFFECT LESS THAN EXPECTED120 reports
INCORRECT DOSE ADMINISTERED117 reports
SINUSITIS117 reports
UNEVALUABLE EVENT117 reports
DISABILITY116 reports
NIGHT SWEATS115 reports
WEIGHT INCREASED115 reports
FEELING DRUNK109 reports
ASTHENIA107 reports
PALPITATIONS105 reports
HYPOAESTHESIA104 reports
TACHYCARDIA103 reports
RESTLESS LEGS SYNDROME102 reports
URINARY TRACT INFECTION102 reports
HYPOTENSION99 reports
NIGHTMARE98 reports
EXPOSURE DURING PREGNANCY97 reports
STRESS97 reports
ABDOMINAL PAIN UPPER95 reports
DEHYDRATION95 reports
HUNGER92 reports
ASTHMA90 reports
MALAISE85 reports
INFLUENZA84 reports
SUICIDE ATTEMPT84 reports
CHEST PAIN83 reports
NOCTURIA83 reports
DRUG INTOLERANCE82 reports
SNORING81 reports
VERTIGO81 reports
EXTRA DOSE ADMINISTERED80 reports
DIABETES MELLITUS79 reports
ALOPECIA78 reports
BIPOLAR DISORDER78 reports
HYSTERECTOMY78 reports
AGITATION77 reports

Report Outcomes

Out of 7,919 classified reports for CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES:

Serious 81.0%Non-Serious 19.0%

The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.

Demographics Breakdown

Reports by Sex

Female5,586 (72.9%)
Male2,075 (27.1%)
Unknown2 (0.0%)

Reports by Age

Age 4397 reports
Age 4597 reports
Age 3596 reports
Age 4192 reports
Age 4288 reports
Age 4786 reports
Age 3785 reports
Age 3284 reports
Age 2982 reports
Age 3380 reports
Age 3678 reports
Age 4478 reports
Age 4077 reports
Age 3076 reports
Age 3475 reports
Age 3975 reports
Age 5175 reports
Age 2574 reports
Age 2774 reports
Age 5074 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

How many FDA adverse event reports are associated with CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES?

This profile reflects 22,248 FDA FAERS reports that mention CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES. Reporting is voluntary and does not prove that the drug caused any listed event.

Which adverse reactions are most often listed for CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES?

Frequently reported terms in FAERS include PRODUCT ADMINISTRATION INTERRUPTED, SURGERY, NAUSEA, PRODUCT DOSE OMISSION ISSUE, ANXIETY, INTENTIONAL DOSE OMISSION. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.

Who manufactures CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES?

Labeling and FAERS entries often list Jazz Pharmaceuticals, Inc. in connection with CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES. Always verify the specific product and NDC with your pharmacist.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.